Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 196-201 , February 2001

Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical management with crotaline fab antivenom

Presented at the North American Congress of Clinical Toxicology’s “Advances in the Management of Snakebite” Symposium, October 1999, La Jolla, CA.

  • Leslie V. Boyer, MD

      Affiliations

    • Department of Pediatrics
    • Department of Pediatrics
    • Arizona Poison and Drug Information Center
    • ,
  • Steven A. Seifert, MD

      Affiliations

    • Arizona Poison and Drug Information Center
    • ,
  • Jeffrey S. Cain, MD

      Affiliations

    • University of Arizona Health Sciences Center, Tucson, AZ; and Darnall Army Community Hospital, Ft. Hood, TX.

Received 20 October 1999 ,Revised 1 November 2000 ,Accepted 1 December 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported in part by Altana, Inc.

☆☆ Address for reprints: Leslie Boyer, MD, Arizona Poison and Drug Information Center, 1501 North Campbell Avenue, Tucson, AZ 85724; 520-626-6229, fax 520-626-2720;,E-mail boyer@pharmacy.arizona.edu .

PII: S0196-0644(01)75897-0

doi: 10.1067/mem.2001.113134

Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 196-201 , February 2001

Article Tools

* Image Usage & Resolution